Listed

Amgen Inc

AMGNNasdaqCIK 318154HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$10.05bnRevenue, Q2 FY2026, three months to 2026-06-30$10.05bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0000318154-26-000126.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 5, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$10.05bnRevenue, Q2 FY2026, three months to 2026-06-30$10.05bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0000318154-26-000126.Report this figure+9.5% on a year earlier
  • Gross marginnot reported (Gross profit not reported)No year-earlier figure to compare
  • Operating margin35.0%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $3.51bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0000318154-26-000126.Revenue: $10.05bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0000318154-26-000126.Report this figure+6.0 pts on a year earlier
  • Net margin23.6%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $2.38bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0000318154-26-000126.Revenue: $10.05bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0000318154-26-000126.Report this figure+8.0 pts on a year earlier
  • Diluted EPS$4.37Diluted EPS, Q2 FY2026, three months to 2026-06-30$4.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0000318154-26-000126.Report this figure+64.9% on a year earlier
  • Free cash flow$3.49bnFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $4.00bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0000318154-26-000126. Derived: 6-month figure less the 3-month figure.Capital expenditure: $513.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0000318154-26-000126. Derived: 6-month figure less the 3-month figure.Report this figure+82.6% on a year earlier

Last eight quarters

Full statements
Revenue$10.05bnOperating margin 35.0%
Diluted EPS$4.37, Q2 FY2026
Free cash flow$3.49bn, Q2 FY2026
Amgen Inc, key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$bn8.5Revenue, Q3 FY2024, three months to 2024-09-30$8.50bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0000318154-25-000072.Report this figure9.1Revenue, Q4 FY2024, three months to 2024-12-31$9.09bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000318154-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure8.1Revenue, Q1 FY2025, three months to 2025-03-31$8.15bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0000318154-26-000057.Report this figure9.2Revenue, Q2 FY2025, three months to 2025-06-30$9.18bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0000318154-26-000126.Report this figure9.6Revenue, Q3 FY2025, three months to 2025-09-30$9.56bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0000318154-25-000072.Report this figure9.9Revenue, Q4 FY2025, three months to 2025-12-31$9.87bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000318154-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure8.6Revenue, Q1 FY2026, three months to 2026-03-31$8.62bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0000318154-26-000057.Report this figure10.1Revenue, Q2 FY2026, three months to 2026-06-30$10.05bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0000318154-26-000126.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%24.1%Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: $2.05bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0000318154-25-000072.Revenue: $8.50bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0000318154-25-000072.Report this figure25.4%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $2.31bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-13, accession 0000318154-26-000010. Derived: 12-month figure less the 9-month figure.Revenue: $9.09bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000318154-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure14.5%Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $1.18bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-01, accession 0000318154-26-000057.Revenue: $8.15bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0000318154-26-000057.Report this figure28.9%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $2.66bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0000318154-26-000126.Revenue: $9.18bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0000318154-26-000126.Report this figure26.4%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $2.53bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0000318154-25-000072.Revenue: $9.56bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0000318154-25-000072.Report this figure27.6%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $2.72bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-13, accession 0000318154-26-000010. Derived: 12-month figure less the 9-month figure.Revenue: $9.87bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000318154-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure30.9%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $2.67bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-01, accession 0000318154-26-000057.Revenue: $8.62bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0000318154-26-000057.Report this figure35.0%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $3.51bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0000318154-26-000126.Revenue: $10.05bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0000318154-26-000126.Report this figure
Net margin%33.3%Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: $2.83bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0000318154-25-000072.Revenue: $8.50bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0000318154-25-000072.Report this figure6.9%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $627.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0000318154-26-000010. Derived: 12-month figure less the 9-month figure.Revenue: $9.09bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000318154-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure21.2%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $1.73bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-01, accession 0000318154-26-000057.Revenue: $8.15bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0000318154-26-000057.Report this figure15.6%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $1.43bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0000318154-26-000126.Revenue: $9.18bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0000318154-26-000126.Report this figure33.7%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $3.22bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0000318154-25-000072.Revenue: $9.56bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0000318154-25-000072.Report this figure13.5%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $1.33bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0000318154-26-000010. Derived: 12-month figure less the 9-month figure.Revenue: $9.87bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000318154-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure21.1%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $1.82bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-01, accession 0000318154-26-000057.Revenue: $8.62bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0000318154-26-000057.Report this figure23.6%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $2.38bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0000318154-26-000126.Revenue: $10.05bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0000318154-26-000126.Report this figure
Diluted EPS$ per share5.22Diluted EPS, Q3 FY2024, three months to 2024-09-30$5.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0000318154-25-000072.Report this figurenot reported (Diluted EPS not reported)3.20Diluted EPS, Q1 FY2025, three months to 2025-03-31$3.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-01, accession 0000318154-26-000057.Report this figure2.65Diluted EPS, Q2 FY2025, three months to 2025-06-30$2.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0000318154-26-000126.Report this figure5.93Diluted EPS, Q3 FY2025, three months to 2025-09-30$5.93 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0000318154-25-000072.Report this figurenot reported (Diluted EPS not reported)3.34Diluted EPS, Q1 FY2026, three months to 2026-03-31$3.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-01, accession 0000318154-26-000057.Report this figure4.37Diluted EPS, Q2 FY2026, three months to 2026-06-30$4.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0000318154-26-000126.Report this figure
Free cash flow$bn3.3Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $3.57bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0000318154-25-000072. Derived: 9-month figure less the 6-month figure.Capital expenditure: $257.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0000318154-25-000072. Derived: 9-month figure less the 6-month figure.Report this figure4.4Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $4.77bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0000318154-26-000010. Derived: 12-month figure less the 9-month figure.Capital expenditure: $371.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0000318154-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure1.0Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $1.39bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-01, accession 0000318154-26-000057.Capital expenditure: $411.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-01, accession 0000318154-26-000057.Report this figure1.9Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $2.28bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0000318154-26-000126. Derived: 6-month figure less the 3-month figure.Capital expenditure: $369.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0000318154-26-000126. Derived: 6-month figure less the 3-month figure.Report this figure4.2Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $4.68bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0000318154-25-000072. Derived: 9-month figure less the 6-month figure.Capital expenditure: $436.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0000318154-25-000072. Derived: 9-month figure less the 6-month figure.Report this figure1.0Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $1.60bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0000318154-26-000010. Derived: 12-month figure less the 9-month figure.Capital expenditure: $642.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0000318154-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure1.5Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $2.19bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-01, accession 0000318154-26-000057.Capital expenditure: $712.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-01, accession 0000318154-26-000057.Report this figure3.5Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $4.00bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0000318154-26-000126. Derived: 6-month figure less the 3-month figure.Capital expenditure: $513.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0000318154-26-000126. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$36.75bnOperating margin 24.7%
Diluted EPS$14.23, FY2025
Free cash flow$8.10bn, FY2025
Amgen Inc, key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$bn26.0Revenue, FY2021, twelve months to 2021-12-31$25.98bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-14, accession 0000318154-24-000011.Report this figure26.3Revenue, FY2022, twelve months to 2022-12-31$26.32bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-14, accession 0000318154-25-000010.Report this figure28.2Revenue, FY2023, twelve months to 2023-12-31$28.19bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000318154-26-000010.Report this figure33.4Revenue, FY2024, twelve months to 2024-12-31$33.42bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000318154-26-000010.Report this figure36.8Revenue, FY2025, twelve months to 2025-12-31$36.75bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000318154-26-000010.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%29.4%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $7.64bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-14, accession 0000318154-24-000011.Revenue: $25.98bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-14, accession 0000318154-24-000011.Report this figure36.3%Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: $9.57bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-14, accession 0000318154-25-000010.Revenue: $26.32bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-14, accession 0000318154-25-000010.Report this figure28.0%Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: $7.90bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-13, accession 0000318154-26-000010.Revenue: $28.19bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000318154-26-000010.Report this figure21.7%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $7.26bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-13, accession 0000318154-26-000010.Revenue: $33.42bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000318154-26-000010.Report this figure24.7%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $9.08bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-13, accession 0000318154-26-000010.Revenue: $36.75bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000318154-26-000010.Report this figure
Net margin%22.7%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $5.89bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-14, accession 0000318154-24-000011.Revenue: $25.98bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-14, accession 0000318154-24-000011.Report this figure24.9%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $6.55bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-14, accession 0000318154-25-000010.Revenue: $26.32bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-14, accession 0000318154-25-000010.Report this figure23.8%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $6.72bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0000318154-26-000010.Revenue: $28.19bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000318154-26-000010.Report this figure12.2%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $4.09bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0000318154-26-000010.Revenue: $33.42bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000318154-26-000010.Report this figure21.0%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $7.71bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0000318154-26-000010.Revenue: $36.75bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0000318154-26-000010.Report this figure
Diluted EPS$ per share10.28Diluted EPS, FY2021, twelve months to 2021-12-31$10.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-14, accession 0000318154-24-000011.Report this figure12.11Diluted EPS, FY2022, twelve months to 2022-12-31$12.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-14, accession 0000318154-25-000010.Report this figure12.49Diluted EPS, FY2023, twelve months to 2023-12-31$12.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-13, accession 0000318154-26-000010.Report this figure7.56Diluted EPS, FY2024, twelve months to 2024-12-31$7.56 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-13, accession 0000318154-26-000010.Report this figure14.23Diluted EPS, FY2025, twelve months to 2025-12-31$14.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-13, accession 0000318154-26-000010.Report this figure
Free cash flow$bn8.4Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $9.26bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-14, accession 0000318154-24-000011.Capital expenditure: $880.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-14, accession 0000318154-24-000011.Report this figure8.8Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $9.72bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-14, accession 0000318154-25-000010.Capital expenditure: $936.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-14, accession 0000318154-25-000010.Report this figure7.4Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $8.47bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0000318154-26-000010.Capital expenditure: $1.11bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0000318154-26-000010.Report this figure10.4Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $11.49bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0000318154-26-000010.Capital expenditure: $1.10bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0000318154-26-000010.Report this figure8.1Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $9.96bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0000318154-26-000010.Capital expenditure: $1.86bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0000318154-26-000010.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Amgen Inc
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$17.87bn49,362,016Added+2,261,544
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$12.76bn35,250,101Added+235,869
STATE STREET CORP2026-06-30$11.07bn30,560,537Added+12,049
Capital World Investors2026-06-30$10.53bn29,075,329Reduced−213,014
Invesco Ltd.2026-06-30$5.91bn16,320,446Added+11,748,721
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$5.67bn15,696,068Added+265,544
CHARLES SCHWAB INVESTMENT MANAGEMENT INC2026-06-30$5.44bn15,034,038Added+2,260,652
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$5.38bn14,853,366Added+232,218
MORGAN STANLEY2026-06-30$4.94bn13,653,692Reduced−2,182,366
WELLS FARGO & COMPANY/MN2026-06-30$2.62bn7,235,462Added+147,452

Recent filings

All 2,274 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Amgen Inc, recent filings
FiledFormWhat it isAccession number
2026-10-2717:58 ET8-K5.02 Departure or appointment of officers or directors0000318154-26-000144
2026-08-0518:29 ET10-QQuarterly reportPeriod 2026-06-300000318154-26-000126
2026-08-0416:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000318154-26-000124
2026-07-3116:03 ET8-K1.05 Material cybersecurity incident0000318154-26-000119
2026-05-2016:59 ET8-K5.07 Shareholder vote results0001193125-26-232786
2026-05-1916:08 ET8-K5.02 Departure or appointment of officers or directors0000318154-26-000097
2026-05-0119:04 ET10-QQuarterly reportPeriod 2026-03-310000318154-26-000057
2026-04-3016:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000318154-26-000054
2026-04-2216:03 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000318154-26-000048
2026-04-0716:22 ETDEF 14AProxy statementPeriod 2026-05-190001193125-26-145588

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 13, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
318154
Tickers
AMGN
Exchange
Nasdaq
SIC code
2836 Biological Products, (No Diagnostic Substances)
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 19:36 ET. Listed shows no prices and gives no investment advice.